Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

World’s first dual-chamber leadless pacemaker still going strong after 6 months
Abbott’s Aveir DR leadless pacemaker, the first pacing offering of its kind to gain FDA approval, is linked to a consistent electrical performance six months after implant. Researchers tracked data from nearly 400 patients and presented their full findings in Heart Rhythm.
HRS 2024: Late-breaking clinical trials will highlight key trends in electrophysiology
A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024 in Boston.
Biosense Webster updates 3D heart mapping software with advanced AI models
The update includes multiple new algorithms designed to improve efficiency during cardiac ablation procedures.
Apple Watch AFib feature becomes first-ever digital tool approved by FDA to evaluate medical devices
Healthcare technology companies can now use AFib findings recorded by an Apple Watch to help demonstrate the effectiveness of their devices to the FDA.
Confirmed: AFib ablation more beneficial for patients with HFrEF than those with HFpEF
Researchers explored data from nearly 2,500 AFib ablation patients, sharing their findings in JAMA Cardiology.

Presenter delivers one of the late-breaking electrophysiology (EP) clinical trials at the annual Heart Rhythm meeting sponsored by the Heart Rhythm Society.

HRS Doesn’t Miss a Beat with Cutting-edge Trials

The Heart Rhythm Society focused on the latest developments in electrophysiology and the management of patients with rhythm disorders and heart failure at its 2015 meeting on May 13-16 in Boston. The event included 12 late-breaking clinical trials.

July 7, 2015

Riata, TAVR & legacies

Are Riata concerns a thing of the past and transcatheter aortic valve replacement (TAVR) for almost anyone with severe aortic stenosis the way of the future? Presentations at recent cardiology conferences addressed those questions.

May 22, 2015

HRS statement recommends remote monitoring as standard of care

A panel of experts recommended that remote monitoring become the standard of care for patients with cardiovascular implantable electronic devices (CIEDs), according to a consensus statement from the Heart Rhythm Society (HRS). The statement was published online in Heart Rhythm on May 13.

May 19, 2015

Data shows the CardioMEMS HF System adds incremental benefit when combined with device therapy and is cost effective

St. Jude Medical, Inc., a global medical device company, today announced important new data presented during the Heart Rhythm Society's (HRS) 36th annual Scientific Session supporting improved outcomes and cost-effectiveness of the CardioMEMS™ HF System for the management of Class III heart failure patients.

May 15, 2015

At Heart Rhythm 2015, an international panel of experts provides concise diagnosis and treatment recommendations to improve quality of care for patients with specific cardiovascular syndromes

The Heart Rhythm Society (HRS) has released a first-of-its-kind expert consensus statement on three specific cardiovascular disorders that also involve the autonomic nervous system. The 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope was written by an international group of experts and presented today at Heart Rhythm 2015, the Heart Rhythm Society’s 36th Annual Scientific Sessions.

May 15, 2015

Accreditation for Cardiovascular Excellence (ACE) publishes new standards for electrophysiology (EP) and implantable cardioverter defibrillators (ICD)

Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever electrophysiology (EP) and Implantable Cardioverter Defibrillator (ICD) standards for accreditation. Driven by the latest available clinical evidence, the EP and ICD standards are a comprehensive review of interventional procedures in patients and adults with heart rhythm disorders.

May 13, 2015

Boston Scientific announces scheduled presentations at Heart Rhythm Society 2015

Boston Scientific today announced that key data from 42 abstracts will be featured at the 36th Annual Scientific Sessions of the Heart Rhythm Society (HRS) in Boston on May 13-16.

May 11, 2015

Medtronic to unveil first-of-its-kind clinical data for cardiac therapies at Heart Rhythm 2015

Medtronic plc today announced its schedule of notable clinical studies that will be presented at Heart Rhythm 2015, the Heart Rhythm Society's 36th Annual Scientific Sessions in Boston, including two late-breaking clinical trials featuring the Evera MRI® SureScan® implantable cardioverter-defibrillator (ICD) System and Micra® Transcatheter Pacing System (TPS).

May 6, 2015

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Electrophysiology

World’s first dual-chamber leadless pacemaker still going strong after 6 months

HRS 2024: Late-breaking clinical trials will highlight key trends in electrophysiology

Biosense Webster updates 3D heart mapping software with advanced AI models

Apple Watch AFib feature becomes first-ever digital tool approved by FDA to evaluate medical devices

Confirmed: AFib ablation more beneficial for patients with HFrEF than those with HFpEF

Around the web